# Clinical Efficacy of 125I Seed Implantation in the Treatment of Refractory Differentiated Thyroid Cancer

> **NCT06362772** · — · COMPLETED · sponsor: **Jiangxi Provincial Cancer Hospital** · enrollment: 36 (actual)

## Conditions studied

- Thyroid Neoplasms

## Interventions

- **RADIATION:** Iodine-125 brachytherapy

## Key facts

- **NCT ID:** NCT06362772
- **Lead sponsor:** Jiangxi Provincial Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2022-02-01
- **Final completion:** 2023-04-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06362772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06362772, "Clinical Efficacy of 125I Seed Implantation in the Treatment of Refractory Differentiated Thyroid Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06362772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*